No connection

Search Results

REAX

NEUTRAL
$2.74 Live
The Real Brokerage Inc. · NASDAQ
Target $5.35 (+95.3%)
$2.31 52W Range $5.41

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 18, 2026
Market cap
$581.7M
P/E
N/A
ROE
-19.3%
Profit margin
-0.4%
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
80%
REAX exhibits a stark divergence between fundamental health and growth potential. The deterministic baseline is weak, highlighted by a Piotroski F-Score of 2/9, indicating significant financial instability and poor operational efficiency. However, the company maintains strong top-line momentum with 44.10% YoY revenue growth and a very low Price/Sales ratio of 0.30. While analysts remain aggressively bullish with a target of $5.35, the technical trend is bearish and profitability remains elusive.

Key Strengths

Strong YoY revenue growth of 44.10%
Very attractive Price/Sales ratio (0.30)
Consistent history of beating earnings estimates (3/4 last 4 quarters)
Healthy liquidity with a Current Ratio of 1.41
Strong analyst consensus (Strong Buy) with significant upside potential to target price

Key Risks

Critically low Piotroski F-Score (2/9) signaling poor financial health
Negative profitability metrics (Profit Margin -0.41%, ROE -19.27%)
Severe technical downtrend (0/100 Technical Trend score)
High Price-to-Book ratio (11.14) suggesting overvaluation relative to assets
Negative earnings growth and lack of positive EPS consistency
AI Fair Value Estimate
Based on comprehensive analysis
$3.85
+40.5% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
36
Weak
Value
55
Future
75
Past
30
Health
20
Dividend
0
AI Verdict
High-Risk Growth Play
Key drivers: Revenue expansion, Low P/S valuation, Poor financial health scores, Bearish price action
Confidence
85%
Value
55/100

Trades at a deep discount to sales but a steep premium to book value.

Positives
  • Low P/S ratio of 0.30
Watchpoints
  • High P/B ratio of 11.14
  • No Graham Number due to negative earnings
Future
75/100

Growth is robust, but the path to profitability is not yet clear.

Positives
  • 44% YoY and Q/Q revenue growth
  • Strong analyst price targets
Watchpoints
  • Forward P/E is negative (-68.50)
Past
30/100

Recent price performance is sharply bearish despite long-term gains.

Positives
  • Long term 3Y change is positive (+121%)
Watchpoints
  • 1Y return is -41.3%
  • 6M return is -26.1%
Health
20/100

Deterministic health scores indicate a weak financial foundation.

Positives
  • Current ratio > 1.0
Watchpoints
  • Piotroski F-Score of 2/9
  • Negative ROE and ROA
Dividend
0/100

Company is in a growth phase and does not distribute capital.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$2.74
Analyst Target
$5.35
Upside/Downside
+95.3%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for REAX and closest competitors.

Updated 2026-04-17
REA
The Real Brokerage Inc.
Primary
5Y
+44.2%
3Y
+121.0%
1Y
-41.3%
6M
-26.1%
1M
+14.2%
1W
+12.3%
GOO
Gladstone Commercial Corporation
Peer
5Y
-9.6%
3Y
+27.6%
1Y
-2.5%
6M
+12.2%
1M
-1.0%
1W
+3.7%
BDN
Brandywine Realty Trust
Peer
5Y
-55.0%
3Y
-28.6%
1Y
-35.9%
6M
-22.3%
1M
+8.5%
1W
-2.3%
ADA
Adamas Trust, Inc.
Peer
5Y
-22.7%
3Y
+23.8%
1Y
+35.5%
6M
+17.6%
1M
-1.4%
1W
-1.5%
AHH
Armada Hoffler Properties, Inc.
Peer
5Y
-16.1%
3Y
-29.6%
1Y
-24.2%
6M
+1.9%
1M
+7.0%
1W
-2.4%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-68.5
PEG Ratio
N/A
P/B Ratio
11.14
P/S Ratio
0.3
EV/Revenue
0.27
EV/EBITDA
-80.96
Market Cap
$581.7M

Profitability

Profit margins and return metrics

Profit Margin -0.41%
Operating Margin -0.89%
Gross Margin 8.42%
ROE -19.27%
ROA -4.98%

Growth

Revenue and earnings growth rates

Revenue Growth +44.1%
Earnings Growth N/A
Q/Q Revenue Growth +44.07%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
1.41
Good
Quick Ratio
1.01
Good
Cash/Share
$0.23

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.5B
Gross Margin
7.7%
Op. Margin
-0.9%
Net Margin
-0.8%
Total Assets
$0.1B
Liabilities
$0.1B
Equity
$0.1B
Debt/Equity
1.46x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
-11%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-07
$N/A
2026-03-04
$-0.02
+40.0% surprise
2025-10-30
$N/A
+100.0% surprise
2025-08-07
$0.01
+300.0% surprise

Real Estate Sector Comparison

Comparing REAX against 96 companies in the Real Estate sector (4 bullish, 15 neutral, 77 bearish)
Return on Equity (ROE)
-19.27%
This Stock
vs
-59.26%
Sector Avg
-67.5% (Below Avg)
Profit Margin
-0.41%
This Stock
vs
9.38%
Sector Avg
-104.4% (Weaker)
Revenue Growth
44.1%
This Stock
vs
28456.08%
Sector Avg
-99.8% (Slower)
Current Ratio
1.41
This Stock
vs
6.48
Sector Avg
-78.3% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Rozenblat (Jenna Marie)
Senior Officer of Issuer
Stock Award
2026-03-17
5,284 shares
Lumpkin (Alexandra)
Senior Officer of Issuer
Stock Award
2026-03-17
3,026 shares
Lumpkin (Alexandra)
Senior Officer of Issuer
Stock Award
2026-03-11
23,993 shares
Madden (Andrea)
Senior Officer of Issuer
Stock Award
2026-03-11
23,691 shares
Okmen (Sibel)
Senior Officer of Issuer
Stock Award
2026-03-11
3,789 shares
Damani (Pritesh Ashok)
Senior Officer of Issuer
Stock Award
2026-03-11
44,650 shares
Rozenblat (Jenna Marie)
Senior Officer of Issuer
Stock Award
2026-03-11
41,575 shares
Poleg (Tamir Shlomo)
Director of Issuer
Stock Award
2026-03-11
164,064 shares
Okmen (Sibel)
Senior Officer of Issuer
Stock Award
2026-03-09
Jani (Ravi Hemendra)
Senior Officer of Issuer
Stock Award
2026-02-13
7,456 shares
Rozenblat (Jenna Marie)
Senior Officer of Issuer
Stock Award
2026-02-10
10,245 shares
Poleg (Tamir Shlomo)
Director of Issuer
Option Exercise
2025-12-23
5,046 shares · $1,004
Poleg (Tamir Shlomo)
Director of Issuer
Disposi...
2025-12-23
5,046 shares · $20,184
Poleg (Tamir Shlomo)
Director of Issuer
Option Exercise
2025-12-22
17,026 shares · $3,388
Poleg (Tamir Shlomo)
Director of Issuer
Disposi...
2025-12-22
2,300 shares · $9,062
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
5 analysts
BTIG
2026-04-15
reit
Buy Buy
Benchmark
2026-03-26
init
Buy
Zelman & Assoc
2026-03-05
down
Outperform Neutral
Jones Trading
2026-03-04
Maintains
Buy Buy
BTIG
2026-03-04
Maintains
Buy Buy
Freedom Capital Markets
2026-01-23
init
Buy
Freedom Broker
2026-01-23
init
Buy
Jones Trading
2025-11-05
Maintains
Buy Buy
B. Riley Securities
2025-10-31
reit
Buy Buy
Jones Trading
2025-10-30
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning REAX from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile